Escherichia coli O157:H7

Lancet

Volumn 352, Issue 9135, 1998, Pages 1207-1212

  Mead, Paul S ^a   Griffin, Patricia M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; SHIGA TOXIN;

BACTERIAL VIRULENCE; CATTLE; DIARRHEA; DISEASE TRANSMISSION; ESCHERICHIA COLI O157; FECES; FECES ANALYSIS; FOOD CONTAMINATION; HAND WASHING; HEALTH EDUCATION; HEMOLYTIC UREMIC SYNDROME; HEMORRHAGIC COLITIS; HUMAN; HYGIENE; LABORATORY TEST; PATIENT COUNSELING; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SEROTYPE; WATER CONTAMINATION;

EID: 0032505655     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)01267-7     Document Type: Review

References (58)

1. 1 National Institute of Health and Infectious Disease. Verocytotoxin-producing Escherichia coli (enterohemorrhagic E coli) infections, Japan, 1996-June, 1997. Infectious Agents Surveillance Report 1997; 18: 153-54.
2. 2 Ahmed S, Donaghy M. An outbreak of Escherichia coli O157:H7 in Central Scotland. In: Kaper JB, O'Brien AD, eds. Escherichia coli O157:H7 and other Shiga toxin-producing E coli strains. Washington, DC: ASM Press, 1998: 59-65.
3. 3 CDC. Escherichia coli O157:H7 infections associated with eating a nationally distributed commercial brand of frozen ground beef patties and burgers - Colorado, 1997. MMWR Morb Mortal Wkly Rep 1997; 46: 777-78.
4. 4 Riley LW, Remis RS, Helgerson SD, et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 1983; 308: 681-85.
5. 5 Karmali MA, Steele BT, Petric M, Lim C. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet 1983; i: 619-20.
6. 6 Siegler RL. The hemolytic uremic syndrome. Pediatr Clin North Am 1995; 42: 1505-29.
7. 7 Whittam TS, Wolfe ML, Wachsmuth IK, Orskov F, Orskov I, Wilson RA. Clonal relationships among Escherichia coli strains that cause hemorrhagic colitis and infantile diarrhea. Infect Immun 1993; 61: 1619-29.
8. 8 Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998; 11: 1-60.
9. 9 LeClerc JE, Li B, Payne WL, Cebula TA. High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 1996; 274: 1208-11.
10. 10 Griffin PM, Tauxe RV. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E coli, and the associated hemolytic uremic syndrome. Epidemiol Rev 1991; 13: 60-98.
11. 11 Piel CF, Phibbs RH. The hemolytic-uremic syndrome. Pediatr Clin North Am 1966; 13: 295-314.
12. 12 van Wieringen PMV, Monnens LAH, Schretlen EDAM. Haemolytic-uraemic syndrome. Epidemiological and clinical study. Arch Dis Child 1974; 49: 432-37.
13. 13 Gianantonio C, Vitacco M, Mendilaharzu F, Rutty A, Mendilaharzu J. The hemolytic-uremic syndrome. J Pediatr 1964; 64: 478-91.
14. 14 Tarr PI, Neill MA, Allen J, Siccardi CJ, Watkins SL, Hickman RO. The increasing incidence of the hemolytic-uremic syndrome in King County, Washington: lack of evidence for ascertainment bias. Am J Epidemiol 1989; 129: 582-86.
15. 15 Thomas A, Cheasty T, Frost JA, Chart H, Smith HR, Rowe B. Vero cytotoxin-producing Escherichia coli, particularly serogroup O157, associated with human infections in England and Wales: 1992-4. Epidemiol Infect 1996; 117: 1-10.
16. 16 Cimolai N, Basalyga S, Mah DG, Morrison BJ, Carter JE. A continuing assessment of risk factors for the development of Escherichia coli O157:H7-associated hemolytic uremic syndrome. Clin Nephrol 1994; 42: 85-89.
17. 17 Slutsker L, Ries AA, Greene KD, Wells JG, Hutwagner L, Griffin PM. Escherichia coli O157:H7 diarrhea in the United States: clinical and epidemiologic features. Ann Intern Med 1997; 126: 505-13.
18. 18 National Institute of Health and Infectious Disease. Verocytotoxin-producing Escherichia coli, January 1991-November 1995, Japan. Infectious Agents Surveillance Report 1996; 17: 1-2.
19. 19 Law D, Kelly J. Use of heme and hemoglobin by Escherichia coli O157 and other Shiga-like-toxin-producing E coli serogroups. Infect Immun 1995; 63: 700-02.
20. 20 Moake JL. Haemolytic-uraemic syndrome: basis science. Lancet 1994; 343: 393-97.
21. 21 Reilly WJ. E coli O157 in Scotland - an overview. Scottish Centre for Infection and Environmental Health Weekly Report 1997 (suppl 1,97/13): 4-5.
22. 22 Waters JR, Sharp JC, Dev VJ. Infection caused by Escherichia coli O157:H7 in Alberta, Canada, and in Scotland: a five-year review, 1987-1991. Clin Infect Dis 1994; 19: 834-43.
23. 23 Lopez EL, Diaz M, Grinstein S, et al. Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins. J Infect Dis 1989; 160: 469-75.
24. 24 Rivas M, Balbi L, Miliwebsky ES, et al. Sindrome uremico hemolitico en niños de Mendoza, Argentina asociacion con la infeccion por Escherichia coli productor de toxina Shiga. Medicina 1998; 58: 1-7.
25. 25 Chapman PA, Siddons CA, Malo ATC, Harkin MA. A 1-year study of Escherichia coli O157 in cattle, sheep, pigs and poultry. Epidemiol Infect 1997; 119: 245-50.
26. 26 Hancock DD, Besser TE, Rice DH, Ebel ED, Herriott DE, Carpenter LV. Multiple sources of Escherichia coli O157 in feedlots and dairy farms in the northwestern United States. Preventive Veterinary Med 1998; 35: 11-19.
27. 27 MacDonald IA, Gould IM, Curnow J. Epidemiology of infection due to Escherichia coli O157: a 3-year prospective study. Epidemiol Infect 1996; 116: 279-84.
28. 28 Pierard D. Infections with verotoxin-producing Escherichia coli. Acta Clin Belg 1992; 47: 387-96.
29. 29 Wall PG, McDonnell RJ, Adak GK, Cheasty T, Smith HR, Rowe B. General outbreaks of verocytotoxin producing Escherichia coli O157 in England and Wales from 1992 to 1994. Commun Dis Rep CDR Rev 1996; 6: R26-33.
30. 30 Griffin PM. Escherichia coli O157:H7 and other enterohemorrhagic Escherichia coli. In: Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL, eds. Infections of the gastrointestinal tract. New York: Raven Press, 1995: 739-61.
31. 31 Keene WE, Sazie E, Kok J, et al. An outbreak of Escherichia coli O157:H7 infections traced to jerky made from deer meat. JAMA 1997; 277: 1229-31.
32. 32 Tilden J Jr, Young W, McNamara AM, et al. A new route of transmission for Escherichia coli: infection from dry fermented salami. Am J Publ Hlth 1996; 86: 1142-45.
33. 33 CDC. Outbreaks of Escherichia coli O157:H7 infection associated with eating alfalfa sprouts - Michigan and Virginia, June-July 1997. MMWR Morb Mortal Wkly Rep 1997; 46: 741-44.
34. 34 CDC. Outbreaks of Escherichia coli O157:H7 infection and cryptosporidiosis associated with drinking unpasteurized apple cider -Connecticut and New York, October 1996. MMWR Morb Mortal Wkly Rep 1997; 46: 4-8.
35. 35 Akashi S, Job K, Tsuji A, et al. A severe outbreak of haemorrhagic colitis and haemolytic uraemic syndome associated with Escherichia coli O157:H7 in Japan. Eur J Pediatr 1994; 153: 650-55.
36. 36 Keene WE, McAnulty JM, Hoesly FC, et al. A swimming-associated outbreak of hemorrhagic colitis caused by Escherichia coli O157:H7 and Shigella sonnei. N Engl J Med 1994; 331: 579-84.
37. 37 Carter AO, Borczyk AA, Carlson JA, et al. A severe outbreak of Escherichia coli O157:H7 - associated hemorrhagic colitis in a nursing home. N Engl J Med 1987; 317: 1496-500.
38. 38 Pavia AT, Nichols CR, Green DP, et al. Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations. J Pediatr 1990; 116: 544-51.
39. 39 Belongia EA, Osterholm MT, Soler JT, Ammend DA, Braun JE, MacDonald KL. Transmission of Escherichia coli O157:H7 infection in Minnesota child day-care facilities. JAMA 1993; 269: 883-88.
40. 40 Swerdlow DL, Griffin PM. Duration of faecal shedding of Escherichia coli O157:H7 among children in day-care centres. Lancet 1997; 349: 745-46.
41. 41 Le Saux N, Spika JS, Friesen B, et al. Ground beef consumption in noncommercial settings is a risk factor for sporadic Escherichia coli O157:H7 infection in Canada. J Infect Dis 1993; 167: 500-02.
42. 42 Bell BP, Griffin PM, Lozano P, Christie DL, Kobayashi JM, Tarr PI. Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics 1997; 100: e12.
43. 43 Advisory Committee on the Microbiologic Safety of Food. Report on Verocytotoxin-Producing Escherichia coli. London: HM Stationery Office, 1995.
44. 44 Tarr PI, Neill MA, Clausen CR, Watkins SL, Christie DL, Hickman RO. Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology. J Infect Dis 1990; 162: 553-56.
45. 45 Gunzer F, Bohm H, Russmann H, Bitzan M, Aleksic S, Karch H. Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic-uremic syndrome. J Clin Microbiol 1992; 30: 1807-10.
46. 46 Chart H, Smith HR, Scotland SM, Rowe B, Milford DV, Taylor CM. Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome. Lancet 1991; 337: 138-40.
47. 47 Barrett TJ, Green JH, Griffin PM, Pavia AT, Ostroff SM, Wachsmuth IK. Enzyme-linked immunosorbent assays for detecting antibodies to Shiga-like toxin I, Shiga-like toxin II, and Escherichia coli O157:H7 lipopolysaccharide in human serum. Curr Microbiol 1991; 23: 189-95.
48. 48 Tarr PI. Escherichia coli O157:H7: clinical, diagnostic, and epidemiological aspects of human infection. Clin Infect Dis 1995; 20: 1-8.
49. 49 Milford DV, Taylor CM. New insights into the haemolytic uraemic syndromes. Arch Dis Child 1990; 65: 713-15.
50. 50 Martin DL, MacDonald KL, White KE, Soler JT, Osterholm MT. The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota. N Engl J Med 1990; 323: 1161-67.
51. 51 Proulx F, Turgeon JP, Delage G, Lafleur L, Chicoine L. Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis. J Pediatr 1992; 121: 299-303.
52. 52 Takeda T, Yoshino K, Uchida H, Ikeda N, Tanimura M. Early use of fosfomycin for Shiga Toxin-producing Escherichia coli O157 infection reduces the risk of hemolytic-uremic syndrome. In: Kaper JB, O'Brien AD, eds. Escherichia coli O157:H7 and other shiga-toxin producing E coli strains. Washington, DC: ASM Press, 1998: 385-87.
53. 53 Armstrong GD, Rowe PC, Goodyer P, et al. A phase I study of chemically synthesized verotoxin (Shiga-like toxin) Pk-trisaccharide receptors attached to chromosorb for preventing hemolytic-uremic syndome. J Infect Dis 1995; 171: 1042-45.
54. 54 Lissner R, Schmidit H, Karch H. A standard immunoglobin preparation produced from bovine colostra shows antibody reactivity and neutralization activity against Shiga-like toxins and EHEC-hemolysin of Escherichia coli O157:H7. Infection 1996; 24: 378-83.
55. 55 Tarr PI, Neill MA. Perspective: the problem of non-O157:H7 Shiga toxin (Verocytotoxin)-producing Escherichia coli. J Infect Dis 1996; 174: 1136-39.
56. 56 Bell BP, Goldoft M, Griffin PM, et al. A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhoea and hemolytic uremic syndrome from hamburgers. The Washington experience. JAMA 1994; 272: 1349-53.
57. 57 Bender JB, Hedberg CW, Besser JM, Boxrud DJ, MacDonald KL, Osterholm MT. Surveillance by molecular subtype for Escherichia coli O157:H7 infections in Minnesota by molecular subtyping. N Engl J Med 1997; 337: 388-94.
58. 58 Osterholm MT, Potter ME. Irradiation pasteurization of solid foods: taking food safety to the next level. Emerg Infect Dis 1997; 3: 575-77.